These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36775262)

  • 1. Oral lesions with immunohistochemical evidence of Sars-CoV-2 in swab-negative post-COVID syndrome.
    Limongelli L; Favia G; Maiorano E; D'Amati A; Pispero A; Ingravallo G; Barile G; Tempesta A; Dell'Olio F; Siciliani RA; Capodiferro S
    Oral Dis; 2024 Apr; 30(3):1264-1272. PubMed ID: 36775262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covid-19 and oral diseases: Crosstalk, synergy or association?
    Brandini DA; Takamiya AS; Thakkar P; Schaller S; Rahat R; Naqvi AR
    Rev Med Virol; 2021 Nov; 31(6):e2226. PubMed ID: 33646645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: a systematic review.
    Erbaş GS; Botsali A; Erden N; Arı C; Taşkın B; Alper S; Vural S
    Int J Dermatol; 2022 Jan; 61(1):20-32. PubMed ID: 34549816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
    El Hachem M; Diociaiuti A; Concato C; Carsetti R; Carnevale C; Ciofi Degli Atti M; Giovannelli L; Latella E; Porzio O; Rossi S; Stracuzzi A; Zaffina S; Onetti Muda A; Zambruno G; Alaggio R
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2620-2629. PubMed ID: 32474947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral mucosal lesions and oral symptoms of the SARS-CoV-2 infection.
    Surboyo MD; Ernawati DS; Budi HS
    Minerva Dent Oral Sci; 2021 Aug; 70(4):161-168. PubMed ID: 34269548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Pathology in COVID-19 and SARS-CoV-2 Infection-Molecular Aspects.
    Drozdzik A; Drozdzik M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19.
    Bussani R; Zentilin L; Correa R; Colliva A; Silvestri F; Zacchigna S; Collesi C; Giacca M
    J Pathol; 2023 Mar; 259(3):254-263. PubMed ID: 36651103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral manifestations of Covid-19-A literature review.
    Farid H; Khan M; Jamal S; Ghafoor R
    Rev Med Virol; 2022 Jan; 32(1):e2248. PubMed ID: 34028129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Covid: where we stand and challenges ahead.
    Mantovani A; Morrone MC; Patrono C; Santoro MG; Schiaffino S; Remuzzi G; Bussolati G;
    Cell Death Differ; 2022 Oct; 29(10):1891-1900. PubMed ID: 36071155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female gender is associated with long COVID syndrome: a prospective cohort study.
    Bai F; Tomasoni D; Falcinella C; Barbanotti D; Castoldi R; Mulè G; Augello M; Mondatore D; Allegrini M; Cona A; Tesoro D; Tagliaferri G; Viganò O; Suardi E; Tincati C; Beringheli T; Varisco B; Battistini CL; Piscopo K; Vegni E; Tavelli A; Terzoni S; Marchetti G; Monforte AD
    Clin Microbiol Infect; 2022 Apr; 28(4):611.e9-611.e16. PubMed ID: 34763058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis.
    Noval Rivas M; Porritt RA; Cheng MH; Bahar I; Arditi M
    Front Immunol; 2022; 13():941009. PubMed ID: 35874696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition.
    Limoges MA; Quenum AJI; Chowdhury MMH; Rexhepi F; Namvarpour M; Akbari SA; Rioux-Perreault C; Nandi M; Lucier JF; Lemaire-Paquette S; Premkumar L; Durocher Y; Cantin A; Lévesque S; Dionne IJ; Menendez A; Ilangumaran S; Allard-Chamard H; Piché A; Ramanathan S
    Front Immunol; 2023; 14():1223936. PubMed ID: 37809081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
    Xie Y; Choi T; Al-Aly Z
    JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
    Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 impact on oral health: A general view.
    Parra-Ortega I; Rodriguez-Ortega D
    Bol Med Hosp Infant Mex; 2021 Jan; 78(2):91-94. PubMed ID: 33497372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Manifestation of SARS-CoV-2 infection on oral mouth mucosa].
    Laskowska E; Radwan-Oczko M
    Pol Merkur Lekarski; 2021 Oct; 49(293):374-378. PubMed ID: 34800028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Manifestations of Coronavirus Disease 2019 (COVID-19): A Comprehensive Clinicopathologic and Immunohistochemical Study.
    Soares CD; Souza LL; de Carvalho MGF; Pontes HAR; Mosqueda-Taylor A; Hernandez-Guerrero JC; do Nascimento Medeiros SD; de Oliveira Sales A; Alves FA; Lopes Pinto CA; de Almeida OP
    Am J Surg Pathol; 2022 Apr; 46(4):528-536. PubMed ID: 34720100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.